CP-189 Adherence to abiraterone and enzalutamide in patients with metastatic castration resistant prostate cancer

BackgroundThe use of oral chemotherapy (OC) is an effective and safe approach in the treatment of metastatic castration resistant prostate cancer (MCRP). Abiraterone and enzalutamide offer improved patient convenience and ease of administration. However, patients are now responsible for ensuring opt...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2017-03, Vol.24 (Suppl 1), p.A84-A85
Hauptverfasser:	Nonay, A Alvarez, de Juan-Garcia Torres, P, Gonzalez, L Ruiz, Crespo, M Blanco, Rodriguez, I Perez, Hernandez, A Horta
Format:	Artikel
Sprache:	eng
Schlagworte:	Chemotherapy Drug stores Metastasis Prostate cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!